Work

BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effectsin vitro andin vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases

Year: 1998

Type: article

Source: Pathology & Oncology Research

DOI: 10.1007/bf02905247

Authors: Dean G Tang, Li Li, Zhenyu Zhu, Bindu Joshi, Carl R Johnson, Lawrence J Marnett, Kenneth V Honn, John D Crissman, Stanislaw Krajewski, John C Reed, József Timar, Arthur T. Porter

Institutions: Wayne State University, Vanderbilt University Medical Center, The Barbara Ann Karmanos Cancer Institute, Sanford Burnham Prebys Medical Discovery Institute, Semmelweis University

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G5408184519, APOPTOSIS BASED ANTIPROSTATE CANCER DRUG DEVELOPMENT

OpenAlex ID: W2084765853

FWCI: 0.563

Cites: 43

Cited by: 21

Related to: 10